Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000010

GENERAL COUNSEL & CORP SEC sold 1,457 shares at $29.95 ($43,637)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Allan Jonathan · GENERAL COUNSEL & CORP SEC

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-16 Sale : show line 1 in the form 10b5-1 −1,457 $29.95 $43,637 18,086 D
Open-market sales · 1,457 sh · avg $29.95 · $43,637
Loading xslF345X06/form4-06182026_080652.xml…